Christopher Lübker

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom

Hera Sandhu, Weiwei Xu, Anamaria‐Vera Olivieri et al. · Advances in Therapy · 2023 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes

Phil McEwan, Martin Bøg, Mads Faurby et al. · Journal of Medical Economics · 2025 · 18 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Changes in longevity inequality by education among OECD countries before the COVID-19 pandemic

Christopher Lübker, Fabrice Murtin · BMC Public Health · 2023 · 15 citations · Full text

Social Sciences, Demography, Health Policy +16

The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis

Xiao Wen Luah, Thomas Holst‐Hansen, Christopher Lübker · Diabetes Obesity and Metabolism · 2024 · 12 citations · Full text

Public Health, Health Behavior, Health Assessment +16

Educational inequalities in deaths of despair in 14 OECD countries: a cross-sectional observational study

Christopher Lübker, Fabrice Murtin · Journal of Epidemiology & Community Health · 2024 · 12 citations · Full text

Social Sciences, Demography, Population Health Sciences +17